- Home
- CMPX vs SSP Comparison
CMPX vs SSP Comparison
Compare CMPX & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- SSP
- Stock Information
- Founded
- CMPX 2014
- SSP 1878
- Country
- CMPX United States
- SSP United States
- Employees
- CMPX N/A
- SSP N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- SSP Broadcasting
- Sector
- CMPX Health Care
- SSP Industrials
- Exchange
- CMPX Nasdaq
- SSP Nasdaq
- Market Cap
- CMPX 217.4M
- SSP 173.3M
- IPO Year
- CMPX N/A
- SSP 1988
- Fundamental
- Price
- CMPX $1.54
- SSP $1.97
- Analyst Decision
- CMPX Strong Buy
- SSP Buy
- Analyst Count
- CMPX 2
- SSP 2
- Target Price
- CMPX $9.00
- SSP $7.75
- AVG Volume (30 Days)
- CMPX 366.4K
- SSP 564.8K
- Earning Date
- CMPX 11-07-2024
- SSP 11-01-2024
- Dividend Yield
- CMPX N/A
- SSP N/A
- EPS Growth
- CMPX N/A
- SSP N/A
- EPS
- CMPX N/A
- SSP N/A
- Revenue
- CMPX $850,000.00
- SSP $2,317,391,000.00
- Revenue This Year
- CMPX N/A
- SSP $8.99
- Revenue Next Year
- CMPX $950.68
- SSP N/A
- P/E Ratio
- CMPX N/A
- SSP N/A
- Revenue Growth
- CMPX N/A
- SSP N/A
- 52 Week Low
- CMPX $0.77
- SSP $1.68
- 52 Week High
- CMPX $2.34
- SSP $9.35
- Technical
- Relative Strength Index (RSI)
- CMPX 64.03
- SSP 40.78
- Support Level
- CMPX $1.42
- SSP $1.68
- Resistance Level
- CMPX $1.65
- SSP $2.19
- Average True Range (ATR)
- CMPX 0.13
- SSP 0.13
- MACD
- CMPX 0.01
- SSP 0.03
- Stochastic Oscillator
- CMPX 66.01
- SSP 40.48
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.